Rare diseases
Investigational molecules
Locations
Study of obinutuzumab to reduce PLA2R antibodies in patients with primary membranous nephropathy
The NetherlandsStudy of brentuximab vedotin for maintenance therapy in patients with cutaneous T-cell lymphoma after stem cell transplant
FranceComparing amoxicillin-clavulanate alone versus amoxicillin-clavulanate with ciprofloxacin for treating chemotherapy-induced fever in adult hematology patients
FranceStudy comparing 3-week versus 6-week antibiotic treatment for patients with drained pyogenic liver abscess
FranceStudy of CMP-CPS-001 injection in healthy volunteers and patients with abnormal ornithine transcarbamylase (OTC) genotype for treating urea cycle disorders
The NetherlandsStudy of semaglutide effects on inflammation markers in patients with type 2 diabetes mellitus who have high cardiovascular risk
ItalyEvaluating shorter duration of pembrolizumab and pemetrexed treatment in patients with metastatic non-small cell lung cancer who have not progressed after 6 months
The NetherlandsStudy of amivantamab and pemetrexed for patients with non-small cell lung cancer who have EGFR exon20 insertion mutations and cannot receive platinum therapy
ItalyEvaluating Treatment with Autologous Regulatory T-cells Given by Infusion in Adults with Ulcerative Colitis
GermanyStudy comparing effects of propofol and sevoflurane on kidney blood flow using magnetic resonance imaging in children at risk of post-operative kidney injury
SwedenStudy of eplerenone in patients with heart failure and reduced ejection fraction who also have severe chronic kidney disease
SwedenStudy of intravenous melatonin safety and dosing in newborns with moderate to severe hypoxic-ischaemic encephalopathy receiving therapeutic hypothermia treatment
IrelandTell us about your condition – we search every trial in Europe and connect you with the right site.
